BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28439018)

  • 1. Conservation and divergence of C-terminal domain structure in the retinoblastoma protein family.
    Liban TJ; Medina EM; Tripathi S; Sengupta S; Henry RW; Buchler NE; Rubin SM
    Proc Natl Acad Sci U S A; 2017 May; 114(19):4942-4947. PubMed ID: 28439018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Conservation and E2F Binding Specificity within the Retinoblastoma Pocket Protein Family.
    Liban TJ; Thwaites MJ; Dick FA; Rubin SM
    J Mol Biol; 2016 Oct; 428(20):3960-3971. PubMed ID: 27567532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release.
    Rubin SM; Gall AL; Zheng N; Pavletich NP
    Cell; 2005 Dec; 123(6):1093-106. PubMed ID: 16360038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoblastoma/p107/p130 pocket proteins: protein dynamics and interactions with target gene promoters.
    Stengel KR; Thangavel C; Solomon DA; Angus SP; Zheng Y; Knudsen ES
    J Biol Chem; 2009 Jul; 284(29):19265-71. PubMed ID: 19279001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the retinoblastoma-E2F pathway by the ubiquitin-proteasome system.
    Sengupta S; Henry RW
    Biochim Biophys Acta; 2015 Oct; 1849(10):1289-97. PubMed ID: 26319102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tandem E2F binding sites in the promoter of the p107 cell cycle regulator control p107 expression and its cellular functions.
    Burkhart DL; Wirt SE; Zmoos AF; Kareta MS; Sage J
    PLoS Genet; 2010 Jun; 6(6):e1001003. PubMed ID: 20585628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From G0 to S phase: a view of the roles played by the retinoblastoma (Rb) family members in the Rb-E2F pathway.
    Sun A; Bagella L; Tutton S; Romano G; Giordano A
    J Cell Biochem; 2007 Dec; 102(6):1400-4. PubMed ID: 17979151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential specificity for binding of retinoblastoma binding protein 2 to RB, p107, and TATA-binding protein.
    Kim YW; Otterson GA; Kratzke RA; Coxon AB; Kaye FJ
    Mol Cell Biol; 1994 Nov; 14(11):7256-64. PubMed ID: 7935440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation-induced conformational changes in the retinoblastoma protein inhibit E2F transactivation domain binding.
    Burke JR; Deshong AJ; Pelton JG; Rubin SM
    J Biol Chem; 2010 May; 285(21):16286-93. PubMed ID: 20223825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of RB transcription in vivo by RB family members.
    Burkhart DL; Ngai LK; Roake CM; Viatour P; Thangavel C; Ho VM; Knudsen ES; Sage J
    Mol Cell Biol; 2010 Apr; 30(7):1729-45. PubMed ID: 20100864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cytomegalovirus-encoded viral cyclin-dependent kinase (v-CDK) UL97 phosphorylates and inactivates the retinoblastoma protein-related p107 and p130 proteins.
    Iwahori S; Umaña AC; VanDeusen HR; Kalejta RF
    J Biol Chem; 2017 Apr; 292(16):6583-6599. PubMed ID: 28289097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation.
    Sidle A; Palaty C; Dirks P; Wiggan O; Kiess M; Gill RM; Wong AK; Hamel PA
    Crit Rev Biochem Mol Biol; 1996 Jun; 31(3):237-71. PubMed ID: 8817077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Retinoblastoma (RB) Tumor Suppressor: Pushing Back against Genome Instability on Multiple Fronts.
    Vélez-Cruz R; Johnson DG
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28812991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
    O'Connor RJ; Schaley JE; Feeney G; Hearing P
    Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of the p107 and Rb proteins with E2F during the cell proliferation response.
    Schwarz JK; Devoto SH; Smith EJ; Chellappan SP; Jakoi L; Nevins JR
    EMBO J; 1993 Mar; 12(3):1013-20. PubMed ID: 8458319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
    Li JM; Hu PP; Shen X; Yu Y; Wang XF
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A genetic analysis of the E2F1 gene distinguishes regulation by Rb, p107, and adenovirus E4.
    Cress WD; Johnson DG; Nevins JR
    Mol Cell Biol; 1993 Oct; 13(10):6314-25. PubMed ID: 8413230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RB family tumor suppressor activity may not relate to active silencing of E2F target genes.
    Vormer TL; Wojciechowicz K; Dekker M; de Vries S; van der Wal A; Delzenne-Goette E; Naik SH; Song JY; Dannenberg JH; Hansen JB; Te Riele H
    Cancer Res; 2014 Sep; 74(18):5266-76. PubMed ID: 25056122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
    Kiess M; Gill RM; Hamel PA
    Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoblastoma family proteins have distinct functions in pulmonary epithelial cells in vivo critical for suppressing cell growth and tumorigenesis.
    Simpson DS; Mason-Richie NA; Gettler CA; Wikenheiser-Brokamp KA
    Cancer Res; 2009 Nov; 69(22):8733-41. PubMed ID: 19887614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.